World News: Vaccine makers say they can do it in as little as six weeks, but the authorities need to approve shots faster
Before Sinovac's CoronaVac, the Covid-19 vaccine developed by Chinese pharma company Sinopharm had received a similar 'conditional' approval.
World News: Covid vaccine trials among children are just starting, and they are going to last many months to ensure safety and efficacy
Norway Stockpiles Vaccines For Emergency Use, Will Wait For Pfizer/BioNTech Vaccines By Feb
Rest of World News: Until Friday, Pfizer/BioNTech was the only vaccine available in Norway, and “all deaths are thus linked to this vaccine,” the Norwegian Medicines Agen
India kicks off a crucial leg in the fight against the coronavirus pandemic. As the frontline workers begin to get the COVID-10 shots, here's how the storage, transportation of vaccine vials will be managed.
PM Narendra Modi said on Monday that the Government of India will bear the cost of vaccinating 3 crore health care and frontline workers in the first phase of the vaccination drive against Covid-19.
Almost a year into the COVID-19 pandemic, about 200 vaccine candidates are in the works and 10 have been either approved by several countries or are under limited emergency use.
The European Union said that it has reached a deal with Pfizer and BioNTech for 300 million additional doses of their Covid-19 vaccine.
“With the new agreement, we could purchase a total of up to an additional 300 million doses of the vaccine. In other words, this will allow us to double the number of doses,” President of the European Commission Ursula von der Leyen said.
New research suggests that Pfizerâs COVID-19 vaccine can protect against a mutation found in two highly contagious variants of the coronavirus that erupted in Britain and South Africa.
US News: New research suggests that Pfizer's COVID-19 vaccine can protect against a mutation found in two contagious variants of the coronavirus that erupted i
US News: New research suggests that Pfizer's COVID-19 vaccine can protect against a mutation found in two contagious variants of the coronavirus that erupted i
A study by Pfizer and scientists from the University of Texas Medical Branch indicated the vaccine was effective in neutralizing virus with the so-called N501Y mutation of the spike protein.
The Pfizer-BioNTech COVID vaccine is an mRNA vaccine, administered in two doses to people, in order to prevent infection from the novel coronavirus.
This is a major milestone in the phased vaccination programme being undertaken in the UK as the Oxford jab became the second vaccine approved for rollout after the Pfizer/BioNTech vaccine.
A 32-year-old doctor was hospitalized after receiving the Pfizer-BioNTech Covid-19 vaccine in Mexico. She was admitted to the intensive care unit after she experienced seizures, difficulty breathing and a skin rash. Authorities said has a history of allergic reactions.
According to the experts, allergic reactions to vaccines are rare, with a rate of about 1.3 per 1 million people. They said the mRNA vaccines developed by Pfizer-BioNTech and Moderna will have a similarly low rate of occurrence of allergic reactions.
India News: But it needs time to work, so don’t imagine you are armour-plated the moment a Covid vaccine shoots into your veins
The World Health Organization says it has cleared the Pfizer-BioNTech coronavirus vaccine for emergency use, meaning poorer countries may soon get access to the shot already available in Europe and North America.